Zaloguj się

Gotowe bibliografie tematyczne / Metastatic cancer / Książki

Książki na temat „Metastatic cancer”

Kliknij ten link, aby zobaczyć inne rodzaje publikacji na ten temat: Metastatic cancer.

Autor: Grafiati

Data publikacji: 4 czerwca 2021

Data aktualizacji: 20 lutego 2023

Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych

Wybierz rodzaj źródła:

Sprawdź 50 najlepszych książek naukowych na temat „Metastatic cancer”.

Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.

Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.

Przeglądaj książki z różnych dziedzin i twórz odpowiednie bibliografie.

1

Swanton, Charles, i Stephen R. D. Johnston. Handbook of metastatic breast cancer. Wyd. 2. New York: Informa Healthcare, 2011.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

2

Sherbet, G. V. The Metastatic Spread of Cancer. London: Palgrave Macmillan UK, 1987. http://dx.doi.org/10.1007/978-1-349-09577-3.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

3

Kaufmann, M. Therapeutic management of metastatic breast cancer. Berlin: Walter de Gruyter & Co, 1989.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

4

Leong, Stanley P. L., red. From Local Invasion to Metastatic Cancer. Totowa, NJ: Humana Press, 2009. http://dx.doi.org/10.1007/978-1-60327-087-8.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

5

Metastatic cancer: Clinical and biological perspectives. Austin, Texas, USA: Landes Bioscience, 2013.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

6

1952-, Wick Mark R., red. Metastatic carcinomas of unknown origin. New York: DEMOS, 2008.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

7

Chu, Edward. New treatment strategies for metastatic colorectal cancer. [Manhasset, NY]: CMP Medica, 2008.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

8

New treatment paradigms in metastatic breast cancer. [Manhasset, NY]: CMPMedica, 2008.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

9

Chu, Edward. New treatment strategies for metastatic colorectal cancer. [Manhasset, NY]: CMP Medica, 2008.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

10

Evans, Clive W. The metastatic cell: Behaviour and biochemistry. London: Chapman and Hall, 1991.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

11

Holding tight, letting go: Living with metastatic breast cancer. Cambridge: O'Reilly, 1997.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

12

Shockney, Lillie. 100 questions & answers about advanced and metastatic breast cancer. Wyd. 2. Sudbury, Mass: Jones & Bartlett Learning, 2012.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

13

TxNxM1: The anatomy and clinics of metastatic cancer. Boston: Kluwer Academic Publishers, 2002.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

14

Scheel, Camille. Camp chemo: Postcards home from metastatic breast cancer. Edina, MN: Beaver's Pond Press, 2015.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

15

Hosseini, Hedayatollah. Molecular mechanism of early metastatic breast cancer dissemination. Regensburg: Universitätsbibliothek Regensburg, 2017.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

16

Peter, Thomas. Metastatic potential of human colorectal cancer cell lines. Austin: R.G. Landes Co., 1993.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

17

Piñeiro, Roberto, red. Circulating Tumor Cells in Breast Cancer Metastatic Disease. Cham: Springer International Publishing, 2020. http://dx.doi.org/10.1007/978-3-030-35805-1.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

18

Herfarth, Christian, Peter Schlag i Peter Hohenberger, red. Therapeutic Strategies in Primary and Metastatic Liver Cancer. Berlin, Heidelberg: Springer Berlin Heidelberg, 1986. http://dx.doi.org/10.1007/978-3-642-82635-1.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

19

Sara, Booth, i Bruera Eduardo, red. Palliative care consultations in primary and metastatic brain tumours. Oxford: Oxford University Press, 2004.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

20

Orthopaedic management of metastatic bone disease. St. Louis: Mosby, 1988.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

21

Shockney, Lillie. 100 Q&A about advanced and metastatic breast cancer. Sudbury, Mass: Jones and Bartlett, 2009.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

22

Mayer, Musa. Advanced breast cancer: A guide to living with metastatic disease. Wyd. 2. Beijing: O'Reilly, 1998.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

23

Shockney, Lillie. 100 questions & answers about advanced and metastatic breast cancer. Wyd. 2. Sudbury, Mass: Jones & Bartlett Learning, 2012.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

24

Balaji, K. C., red. Managing Metastatic Prostate Cancer In Your Urological Oncology Practice. Cham: Springer International Publishing, 2016. http://dx.doi.org/10.1007/978-3-319-31341-2.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

25

Shockney, Lillie. 100 questions & answers about advanced and metastatic breast cancer. Wyd. 2. Sudbury, Mass: Jones & Bartlett Learning, 2012.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

26

illustrator, Smith Christina G., red. The cancer that wouldn't go away: A story for kids about metastatic cancer. [United States]: [ICGtesting], 2013.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

27

Miele, Carol A. Metastatic madness: How I coped with a stage 4 cancer diagnosis. Bloomington, Indiana]: Xlibris, 2012.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

28

Jena, Vinod. Metastatic Cancer Chemistry. Lulu Press, Inc., 2016.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

29

Sherbet, R. Metastatic Spread of Cancer. Palgrave Macmillan, 2015.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

30

McDonald, Elizabeth S., Azadeh Elmi i David A. Mankoff. Breast Cancer Metastatic Imaging. Redaktorzy Christoph I. Lee, Constance D. Lehman i Lawrence W. Bassett. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780190270261.003.0010.

Pełny tekst źródła

Streszczenie:

This chapter reviews appropriate indications for advanced imaging, such as PET/CT, in the evaluation of breast cancer. An informed imaging approach is based on primary tumor size and pathological characteristics, as well as patient symptoms that may indicate a higher likelihood of metastatic disease. When evaluation for metastatic disease is indicated, survey imaging with CT, bone scintigraphy, abdominal MRI, brain MRI, and/or PET/CT can be used to establish disease burden, and to identify a biopsy target for pathological confirmation. We emphasize the evolving role of FDG PET/CT in this chapter, including basic principles of PET imaging, followed by a short section on image interpretation. Finally, the concept of using imaging as a response biomarker is introduced.

Style APA, Harvard, Vancouver, ISO itp.

31

Health, Jumo. Understanding Metastatic Breast Cancer. Jumo Health, 2021.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

32

Mahon, Suzanne Marie Dubuque. PSYCHOSOCIAL ADJUSTMENT TO RECURRENT CANCER (METASTATIC CANCER, CANCER). 1991.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

33

Wong, Han Hsi, Basma Greef i Tim Eisen. Treatment of metastatic renal cancer. Redaktor James W. F. Catto. Oxford University Press, 2017. http://dx.doi.org/10.1093/med/9780199659579.003.0089.

Pełny tekst źródła

Streszczenie:

Metastatic renal cancer is resistant to standard chemotherapy. Although some patients with indolent disease can be initially managed with observation, the majority of patients will require aggressive treatment soon after diagnosis. Options include cytoreductive nephrectomy, resection of a solitary metastasis in highly selected cases, or systemic therapy options. The TKIs sunitinib and pazopanib are currently the first-line treatments of choice. Whilst axitinib and cabozantinib have important roles in the second line the PD-1 checkpoint inhibitor, nivolumab, is now established as standard second line therapy. Inhibitors of the mammalian target of rapamycin (mTOR) pathway, everolimus and temsirolimus, interleukin-2 as well as the anti-angiogenic antibody bevacizumab have also been shown to be effective. The treatment paradigm of metastatic renal cancer is constantly changing as evidence from clinical trials continues to emerge. With the development of agents addressing novel targets such as T-cell regulation, the future certainly looks brighter for patients diagnosed with this disease.

Style APA, Harvard, Vancouver, ISO itp.

34

Johnston, Stephen, i Charles Swanton. Handbook of Metastatic Breast Cancer. Informa Healthcare, 2006.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

35

Swanton, Charles, i Stephen R. D. Johnston. Handbook of Metastatic Breast Cancer. Taylor & Francis Group, 2011.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

36

A, Rosenberg Steven, red. Surgical treatment of metastatic cancer. Philadelphia: Lippincott, 1987.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

37

Clarke, Noel W. Metastatic disease in prostate cancer. Redaktor James W. F. Catto. Oxford University Press, 2017. http://dx.doi.org/10.1093/med/9780199659579.003.0068.

Pełny tekst źródła

Streszczenie:

Metastases are the predominant cause of morbidity and death from prostate cancer (CaP). The tendency for cells to migrate from the primary site, enter the vascular/lymphatic circulation, and implant/grow at secondary sites is the principal discriminator of aggressive form indolent disease. But this process is poorly understood. Cells enter the circulation in increasing number as the disease progresses, impinging on endothelial surfaces, particularly in red bone marrow where they bind and transmigrate, forming early cell colonies. This requires chemo-attractants and nutrients enabling cellular survival. Established metastases thrive independently, disrupting local tissue, as characterized by progressive replacement of red bone marrow and disruption of skeletal architecture. Bone disruption includes massive overstimulation of both osteoblasts and osteoclasts, inducing synchronous over-production of abnormal bone and gross osteolysis.

Style APA, Harvard, Vancouver, ISO itp.

38

Calabrò, Fabio, i Cora N. Sternberg. Treatment of metastatic bladder cancer. Redaktor James W. F. Catto. Oxford University Press, 2017. http://dx.doi.org/10.1093/med/9780199659579.003.0079.

Pełny tekst źródła

Streszczenie:

Although bladder cancer is considered a chemosensitive malignancy, the prognosis of patients with metastatic disease is poor, with a median survival of approximately 12–14 months in good prognosis patients and with cure in only a minority. The addition of new drugs to the standard cisplatin-based regimens has not improved these outcomes. In this chapter, we highlight the role of chemotherapy and the impact of the new targeted agents in the treatment of metastatic bladder carcinoma. A better understanding of the underlying biology and the molecular patterns of urothelial bladder cancer has led to clinical investigation of several therapeutic targets. To date, these agents have yet to demonstrate an improvement in overall survival. Urothelial cancer is extremely sensitive to checkpoint inhibition with both anti PD-1 and anti PDL1 antibodies. The future seems brighter with the advent of these new therapies.

Style APA, Harvard, Vancouver, ISO itp.

39

The Metastatic Spread of Cancer. Palgrave Macmillan, 1987.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

40

Swanton, Charles, i Stephen R. D. Johnston, red. Handbook of Metastatic Breast Cancer. CRC Press, 2011. http://dx.doi.org/10.3109/9781841848129.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

41

Swanton, Charles, i Stephen Johnston. Handbook of Metastatic Breast Cancer. Redaktorzy Charles Swanton i Stephen R. D. Johnston. CRC Press, 2006. http://dx.doi.org/10.3109/9780203696910.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

42

Swanton, Charles, i Stephen R. D. Johnston. Handbook of Metastatic Breast Cancer. Taylor & Francis Group, 2019.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

43

Swanton, Charles, i Stephen Johnston. Handbook of Metastatic Breast Cancer. Taylor & Francis Group, 2006.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

44

Swanton, Charles, i Stephen R. D. Johnston. Handbook of Metastatic Breast Cancer. Taylor & Francis Group, 2011.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

45

Wick, Mark R. Metastatic Carcinomas of Unknown Origin. Springer Publishing Company, Incorporated, 2008.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

46

H, Schroeder Fritz, i Richards B. A, red. Therapeutic principles in metastatic prostatic cancer. New York: A.R. Liss, 1985.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

47

Coleman, Robert, R. M. D. Berenson James i Gregory A. Mundy. The Management of Metastatic Bone Cancer. Not Avail, 2009.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

48

1949-, Enghofer E., Henderson I. Craig i Kaufmann M. 1946-, red. Therapeutic management of metastatic breast cancer. Berlin: Walter de Gruyter, 1989.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

49

Allsop, Matthew J., i Michael Bennett. Undertreatment of pain with metastatic cancer. Redaktorzy Paul Farquhar-Smith, Pierre Beaulieu i Sian Jagger. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780198834359.003.0051.

Pełny tekst źródła

Streszczenie:

The landmark paper discussed in this chapter is ‘Pain and its treatment in outpatients with metastatic cancer’, published by Cleeland et al. in 1994. Cleeland and colleagues provide one of the first epidemiological studies outlining the prevalence of cancer pain in outpatients with metastatic cancer. The study drew attention to the undertreatment of pain and identified predictors of poor pain management, such as discrepancies between patient and health professional judgements regarding the degree of pain-induced interference. Issues highlighted by Cleeland and colleagues persist, including high prevalence of pain reported in patients with metastatic cancer, a lack of clarity on good practice guidelines for assessing pain in patients with cancer, and substandard quality of palliative and end-of-life services by minority ethnic groups. Pain management in outpatients with cancer remains a complex issue, but innovative strategies are emerging to support the role of the health professional and encouraging self-management in patients.

Style APA, Harvard, Vancouver, ISO itp.

50

Kaufmann, M., I. C. Henderson i E. Enghofer, red. Therapeutic Management of Metastatic Breast Cancer. De Gruyter, 1989. http://dx.doi.org/10.1515/9783110888942.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

Oferujemy zniżki na wszystkie plany premium dla autorów, których prace zostały uwzględnione w tematycznych zestawieniach literatury. Skontaktuj się z nami, aby uzyskać unikalny kod promocyjny!